Susquehanna International Group’s Windtree Therapeutics Inc WINT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-2,889
Closed -$19.1K 10666
2015
Q2
$27K Buy
+2,889
New +$40.6K ﹤0.01% 9969
2015
Q1
Sell
-8,386
Closed -$165K 10342
2014
Q4
$136K Sell
8,386
-4,550
-35% -$100K ﹤0.01% 9066
2014
Q3
$333K Sell
12,936
-15,008
-54% -$362K ﹤0.01% 7869
2014
Q2
$697K Buy
27,944
+4,355
+18% +$111K ﹤0.01% 6815
2014
Q1
$710K Buy
23,589
+21,378
+967% +$719K ﹤0.01% 6125
2013
Q4
$69K Sell
2,211
-1,130
-34% -$35.3K ﹤0.01% 8733
2013
Q3
$92K Sell
3,341
-4,091
-55% -$99.2K ﹤0.01% 8110
2013
Q2
$158K Buy
+7,432
New +$183K ﹤0.01% 7602

Other funds holding WINT

Susquehanna International Group's WINT Position: Q3 2015 in Review

Susquehanna International Group sold out of Windtree Therapeutics Inc (WINT) in Q3 2015, closing a stake of 2,889 shares — an estimated $19.1K sold.

Susquehanna International Group first reported a position in WINT in Q2 2013 and held it in 8 quarters. The position peaked at $710K in Q1 2014. 48 funds tracked by Wall St. Rank hold WINT as of Q3 2015.

  • Susquehanna International Group reported no remaining Windtree Therapeutics Inc position as of Q3 2015 after selling out during the quarter.
  • Susquehanna International Group sold 2,889 Windtree Therapeutics Inc shares in Q3 2015, an estimated $19.1K.
  • Susquehanna International Group first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 8 quarters.
  • Susquehanna International Group's Windtree Therapeutics Inc position peaked at $710K in Q1 2014.
  • 48 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q3 2015.

Based on Susquehanna International Group's 13F filing for Q3 2015, filed 16 Nov 2015.